glp-1 agonists reduce inflammation Receptor and the Hallmarks of Aging: A Systems-Level Analysis A Comprehensive Review of the

In 2014, the FDA approved the first of these drugs specifically for weight loss for people with a BMI of 30 and above or a BMI of at least 27 with one weight-related comorbid disease, which affects more than half the U.S

Could become the gold standard once approved

Patients often feel full and rarely feel hungry

According to the World Health Organization (WHO), the global prevalence of obesity has nearly tripled since 1975

GLP-1RA Mechanism of Action GLP-1 (glucagon-like peptide-1) is a hormone secreted by the intestinal tract during feeding, which enhances insulin secretion and inhibits glucagon secretion in a glucose concentration-dependent manner, and delays gastric emptying to reduce the amount of food eaten through central appetite suppression

FLOW) improve atherogenic lipoprotein measures in clinical research (tirzepatide: apoB , apoC-III , triglyceride-rich particles